REYON Pharmaceutical Co., Ltd. (102460.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−26.3x

Market Cap

KRW 184.20B

MomentumView details →

1D Return

−0.40%

YTD Return

−7.51%

RSI (14)

48.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−26.3x

Market Cap

KRW 184.20B

RSI (14)

48.1

MomentumView details →

1D Return

−0.40%

YTD Return

−7.51%

ProfitabilityView details →

Gross Margin

21.48%

Net Margin

−24.02%

EBITDA Margin

−10.46%

ROE (TTM)

−17.67%

ROA (TTM)

−7.75%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

−4.45%

EPS YoY

—

FCF YoY

+108.20%

Revenue CAGR 3Y

−1.79%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

1.11x

Current Ratio

0.50x

Quick Ratio

0.26x

Div Yield

—

Div Rate

—

Div Growth 1Y

+18.00%

Financials snapshotView financials →

Revenue (TTM)

143.37B

Net Income (TTM)

−34.44B

Op. CF (TTM)

5.95B

Latest newsMore news →

No recent news for 102460.KS.

Similar companies

AptaBio Therapeutics Inc.293780.KQ Whan In Pharm Co.,Ltd.016580.KS FutureChem Co.,Ltd220100.KQ JW Lifescience Corporation234080.KS Daewon Pharmaceutical Co., Ltd.003220.KS Hyundai Pharmaceutical Co., Ltd.004310.KS Find similar companies →

Latest newsMore news →

No recent news for 102460.KS.